Table 4.
Multivariate analysis of the patients dataset for OS without (A) and including (B) imaging biomarkers.
| p value | HR | 95% CI for HR | ||
|---|---|---|---|---|
| Lower | Upper | |||
| (A) | ||||
| Gender (F vs M) | 0.042 | 8.036 | 1.082 | 59.770 |
| Age | 0.017 | 1.057 | 1.012 | 1.109 |
| Stage (III vs IV) | 0.262 | 1.734 | 0.663 | 4.535 |
| OvsL | 0.895 | 0.937 | 0.395 | 2.029 |
| Novscht | 0.317 | 1.916 | 0.521 | 7.051 |
|
| ||||
| (B) | ||||
| Gender (F vs M) | 0.090 | 5.75E + 00 | 7.90E − 01 | 4.81E + 01 |
| Age | 0.011 | 1.05E + 00 | 1.01E + 00 | 1.09E + 00 |
| Stage (III vs IV) | 0.341 | 1.59E + 00 | 5.82E − 01 | 3.83E + 00 |
| LILRE | 0.635 | 7.08E − 05 | 9.72E − 25 | 8.35E + 9 |
| SUL peak | 0.068 | 1.10E + 00 | 1.009E + 00 | 1.192E + 00 |